Identification
Personal identification
- Full name
- Mariana Pinto Coelho
Citation names
- Coelho, Mariana
Author identifiers
- Ciência ID
- F018-59A8-6A23
- ORCID iD
- 0000-0002-8168-7267
- Scopus Author Id
- 58169549800
Email addresses
- mariana.coelho@ff.ulisboa.pt (Professional)
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English | Upper intermediate (B2) | Advanced (C1) | Upper intermediate (B2) | Upper intermediate (B2) | |
Portuguese (Mother tongue) |
Education
Degree | Classification | |
---|---|---|
2023/12 - 2023/12
Concluded
|
Translating Nanomedicines: Principles of Nanomedicines R&D (Curso de doutoramento (conclusão de unidades curriculares))
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
19 |
2023/01 - 2023/09
Concluded
|
Atualização de Ciências em Animais de laboratório (Pós-Graduação)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
17 |
2019 - 2022
Concluded
|
Engenharia Química e Biológica (Mestrado)
Major in Bioprocessos
Instituto Politécnico de Lisboa Instituto Superior de Engenharia de Lisboa, Portugal
"Extratos de algas marinhas comestíveis aplicados para a redução do risco de doenças cardiovasculares" (THESIS/DISSERTATION)
|
16 |
2016 - 2019
Concluded
|
Engenharia Química e Biológica (Licenciatura)
Major in Processos Biológicos
Instituto Politécnico de Lisboa Instituto Superior de Engenharia de Lisboa, Portugal
|
14 |
Affiliation
Others
Category Host institution |
Employer | |
---|---|---|
2023/07 - Current | Bolseira de investigação no projeto PTDC/QUI-QIN/0586/2020 "Novel nanoplatforms for targeting melanoma with 8-hydroxyquinoline metal complexes" | Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento, Portugal |
Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento, Portugal | ||
2022/12 - 2023/06 | Bolseira de Investigação no projeto "SkanAbility - Proof of concept for biological activity of cannabinoids and terpenes - cosmeceutical applications" | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2021/10 - 2022/10 | Quality Assurance trainee | Hikma Pharmaceuticals, Portugal |
Projects
Contract
Designation | Funders | |
---|---|---|
2023/07 - Current | Novel nanoplatforms for targeting melanoma with 8-hydroxyquinoline metal complexes
PTDC/QUI-QIN/0586/2020
Research Fellow
Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento, Portugal
|
Ongoing
|
2022/12 - 2023/06 | SkanAbility - Proof of concept for biological activity of cannabinoids and terpenes - cosmeceutical applications
NORTE 01 0247 FEDER 047213
Research Fellow
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Concluded
|
2022/11 - 2022/12 | Rifabutin Liposomes - a novel nanotechnological strategy for effective treatment of systemic methicilin-resistant staphylococus
aureus infections.
MMG-2021-092/1-1
Participação no projeto
Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento, Portugal
|
Ongoing
|
Outputs
Publications
Conference poster |
|
Journal article |
|
Preprint |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2024/07 | Advancing the treatment of infectious diseases - the key role of liposomes as delivery systems | Workshop - Recent advances in the use of phospholipids excipients, Integrating Delivery Science across disciplines
Controlled Release Society (CRS) (Bolonha, Italy)
|
2024/02 | Advancing the treatment of Staphylococcus aureus with rifabutin-loaded liposomes - in vitro and in vivo studies | Spanish Portuguese Local Chapter - Controlled Release Society (SPLC-CRS)
Faculty of Pharmacy, Universidade de Lisboa (Lisboa, Portugal)
|
2023/11 | Oxidovanadium(IV) complexes containing 8-hydroxyquinoline Schiff bases – synthesis, characterization and biological screening | 13th International Vanadium Symposium
Calouste Gulbenkian Foundation, Lisboa (Portugal)
|
2023/03/18 | Exploring rifabutin liposomes as a novel therapeutic approach against Staphylococcus aureus infections | Update on antimicrobial research: Joint struggle against the silent pandemic
Universitat Heidelberg
|